BIT:CPR • NL0015435975
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DAVIDE CAMPARI-MILANO NV (CPR.MI).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-27 | ROTHSCHILD & CO REDBURN | Maintains | Sell -> Sell |
| 2026-01-26 | Berenberg | Maintains | Hold -> Hold |
| 2023-12-21 | EQUITA SIM | Maintains | Hold -> Hold |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.698B 24.16% | 2.919B 8.19% | 3.07B 5.18% | 3.084B 0.47% | 3.122B 1.23% | 3.278B 5.00% | 3.556B 8.48% | 3.756B 5.62% | 3.626B -3.46% | 3.752B 3.47% | 3.877B 3.33% | 4B 3.17% | |
| EBITDA YoY % growth | 652.4M 29.68% | 725.3M 11.17% | 782.3M 7.86% | 761.83M -2.62% | 787.03M 3.31% | 845.75M 7.46% | 947.94M 12.08% | 998.95M 5.38% | 1.521B 52.26% | N/A | N/A | N/A | |
| EBIT YoY % growth | 561.9M 32.71% | 615.1M 9.47% | 654.6M 6.42% | 622.25M -4.94% | 646.88M 3.96% | 695.71M 7.55% | 791.22M 13.73% | 865.66M 9.41% | 1.022B 18.06% | 1.071B 4.79% | N/A | N/A | |
| Operating Margin | 20.83% | 21.08% | 21.32% | 20.18% | 20.72% | 21.22% | 22.25% | 23.05% | 28.19% | 28.54% | N/A | N/A | |
| EPS YoY % growth | N/A 27.27% | N/A -0.28% | N/A -13.43% | 0.30 1.84% | 0.32 7.18% | 0.36 12.23% | 0.45 22.99% | 0.51 13.07% | 0.71 40.99% | N/A | N/A | N/A |
All data in EUR
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | 0.29 |
| Revenue Q2Q % growth | 773.39M -2.44% |
| EBITDA Q2Q % growth | 107.58M -74.62% |
| EBIT Q2Q % growth | 98.054M -66.90% |
All data in EUR
27 analysts have analysed CPR.MI and the average price target is 7.1 EUR. This implies a price increase of 14.62% is expected in the next year compared to the current price of 6.198.
DAVIDE CAMPARI-MILANO NV (CPR.MI) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 0.29 EUR and the consensus revenue estimate is 773.39M EUR.
The expected long term growth rate for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 2.4%.